2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Çý¸², ¹ö³ªµå ¹Ú Ȥ½Ã Ä¿ÇÃÀ̼¼¿ä? (2016-04-05)
Á¶ÇöÁØ È¿¼º ȸÀå ¡°MZ ÀÎÀç°¡ ȸ»çÀÇ ¹Ì·¡¡± (2023-07-06)
³×À̹ö, ÀΰøÁö´É ±â¹Ý ÀÚµ¿Å뿪 ¾Û ¡®ÆÄÆÄ°í¡¯ Ãâ½Ã (2016-08-09)
½ÅÁ¦Ç° Çʸ³½º ÇìµåÆù TAH8856, TAT5556 (2022-05-24)
À½¿ø ¹ßÇ¥ÇÏ´Â °É±×·ì, ²ÉµéÀÇ ÀüÀï (2016-03-21)
µµ½ÃÀç»ý Âü¿© ÁÖ¹Î, ¸¶À»°­»ç·Î ´Ù¸¥ Áö¿ª µ½´Â´Ù (2018-01-25)
¾Ë¶óµò, ºñ¹Ð¹øÈ£ ÇÊ¿ä ¾ø´Â °£Æí°áÁ¦ (2021-04-11)
¼±¹Ú¿ë ¼ö¼Ò¿¬·áÀüÁö ½Ã½ºÅÛ »ó¿ëÈ­ ÃßÁø (2021-07-09)
¾ÛÀ¸·Î Àú»ó¹ö½º ¹èÂ÷-¿¹¾à-½ÂÇÏÂ÷ ¡®¿ø½ºÅ顯 (2022-11-18)
º¸°Çº¹ÁöºÎ, Çູ³ª´®ìÑ 32¸í ¼±Á¤ (2014-12-17)
Çѱ¹°¥µîÁ¶Á¤ÁøÈï¿ø, Áý´ÜºÐÀï ¹Î¿øÇØ°á ¹°²¿ (2020-05-27)
ºÒȲ ¼Ó À¯¸ÁÁ÷Á¾ »çȸº¹Áö»ç¡¤º¸À°±³»ç (2014-09-04)
»ï¼ºÀüÀÚ ¿Â¶óÀνºÅä¾î¿¡ ÅäÁ¾ SW ¡®³ÝÆÛ³Ú¡¯ (2021-03-27)
¼¼°è¿¡¼­ °¡Àå ºü¸¥ ´ë¿ë·® VPX SSD µå¶óÀ̺ê (2021-06-24)
¼öµµ²ÀÁö ¼³Ä¡ Á¦Ç°, À§»ý¾ÈÀü±âÁØ ÀÎÁõ ¹Þ¾Æ¾ß (2015-03-23)
¡®¼öµ¾¹°¸Ô±â Âü¿©ÀÚ ½£¡¯ Á¶¼º (2015-12-15)
½º³Ê±×ÄÚ¸®¾Æ, Ãâ»ê À°¾Æ¿ëǰ Á¤±â ÈÄ¿ø (2023-06-21)
Çö´ë¿ÀÅä¿¡¹ö, ³»ºñ°ÔÀÌ¼Ç ½Å±Ô ±â´É 2Á¾ ¾÷µ¥ÀÌÆ® (2023-06-21)
LGÀüÀÚ, ±¤ÆÄ¿Àºì Áß°íº¸»ó À̺¥Æ® (2016-06-10)
¡®ºÎȰ-ÇǾ´Â »î¡¯ ±Ç¼÷ÀÚ 40³â ȸȭ¼¼°è»êÃ¥ Àü½Ã (2019-04-22)
Á¦·ÎÆäÀÌ, ´©Àû °¡¸ÍÁ¡ ¼ö 80¸¸°³ µ¹ÆÄ (2021-03-12)
¹ÙÀ§Àý¸¶À»¡¤È£»ó³îÀÌ µî ¹«Çü¹®È­Àç °ø¿¬ (2015-10-09)
LGÀüÀÚ, 21:9 ¾Õ¼¼¿ö ¼¼°è ¸ð´ÏÅÍ ½ÃÀå ¼±µµ (2014-12-31)
½É¹ö½º, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º Å×½ºÆ® ±Û·Î¹ú ¼­ºñ½º (2020-06-03)
Çѱ¹µµ ¿Ü±¹°øÇ× ´ë»ó º¸¾ÈÆò°¡ ½Ç½Ã (2012-10-28)
       [ÀÌÀü][1]....[2251][2252][2253][2254][2255][2256][2257][2258][2259]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..